Literature DB >> 28119130

No decline in the risk of heart failure after incident atrial fibrillation: A community study assessing trends overall and by ejection fraction.

Alanna M Chamberlain1, Bernard J Gersh2, Alvaro Alonso3, Stephen L Kopecky2, Jill M Killian4, Susan A Weston4, Véronique L Roger5.   

Abstract

BACKGROUND: Patients with atrial fibrillation (AF) experience an increased risk of heart failure (HF). However, data are lacking on current trends in the risk of HF after AF.
OBJECTIVE: The purpose of this study was to describe the temporal trends in HF occurrence after AF in a community cohort of patients with incident AF from 2000 to 2013.
METHODS: Cox regression was used to examine the association of year of AF diagnosis with HF and the predictors of developing HF after AF.
RESULTS: Among 3491 AF patients without prior HF, 750 (21%) developed incident HF over mean follow-up of 3.7 years. Among those with an echocardiogram, 422 (61%) had HF with preserved ejection fraction (HFpEF), and 270 (39%) had HF with reduced ejection fraction (HFrEF). After adjusting for demographics and comorbidities, the risk of developing HF did not change over time (hazard ratio [HR] (95% confidence interval [CI]) per year of AF diagnosis: 1.01 (0.98-1.03) overall; 1.00 (0.98-1.03) for HFpEF; 1.00 (0.96-1.03) for HFrEF). Increasing age, obesity, smoking, diabetes, chronic pulmonary disease, and renal disease were predictors of developing HF. Compared to the Olmsted County, Minnesota, population, a substantial excess risk of developing HF was observed after AF diagnosis [standardized morbidity ratio (95% CI): 9.60 (7.44-12.19), 2.13 (1.56-2.84), and 1.70 (1.34-2.14) at 90 days, 1 year, and 3 years after diagnosis].
CONCLUSION: In the community, HF is a frequent adverse outcome among patients with AF, and HFpEF is more common than HFrEF. The rates of HF after AF have not declined, thus highlighting the importance of continued efforts to improve outcomes in AF.
Copyright © 2017 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Atrial fibrillation; Atrial flutter; Epidemiology; Heart failure; Outcomes

Mesh:

Year:  2017        PMID: 28119130      PMCID: PMC5440203          DOI: 10.1016/j.hrthm.2017.01.031

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  26 in total

Review 1.  Estimation of failure probabilities in the presence of competing risks: new representations of old estimators.

Authors:  T A Gooley; W Leisenring; J Crowley; B E Storer
Journal:  Stat Med       Date:  1999-03-30       Impact factor: 2.373

2.  Incidence of Atrial Fibrillation and Relationship With Cardiovascular Events, Heart Failure, and Mortality: A Community-Based Study From the Netherlands.

Authors:  Rob A Vermond; Bastiaan Geelhoed; Niek Verweij; Robert G Tieleman; Pim Van der Harst; Hans L Hillege; Wiek H Van Gilst; Isabelle C Van Gelder; Michiel Rienstra
Journal:  J Am Coll Cardiol       Date:  2015-09-01       Impact factor: 24.094

3.  2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.

Authors:  Craig T January; L Samuel Wann; Joseph S Alpert; Hugh Calkins; Joaquin E Cigarroa; Joseph C Cleveland; Jamie B Conti; Patrick T Ellinor; Michael D Ezekowitz; Michael E Field; Katherine T Murray; Ralph L Sacco; William G Stevenson; Patrick J Tchou; Cynthia M Tracy; Clyde W Yancy
Journal:  Circulation       Date:  2014-03-28       Impact factor: 29.690

Review 4.  Diagnostic criteria for diastolic heart failure.

Authors:  R Frederick Yturralde; William H Gaasch
Journal:  Prog Cardiovasc Dis       Date:  2005 Mar-Apr       Impact factor: 8.194

5.  Impact of CARDIOrespiratory FITness on Arrhythmia Recurrence in Obese Individuals With Atrial Fibrillation: The CARDIO-FIT Study.

Authors:  Rajeev K Pathak; Adrian Elliott; Melissa E Middeldorp; Megan Meredith; Abhinav B Mehta; Rajiv Mahajan; Jeroen M L Hendriks; Darragh Twomey; Jonathan M Kalman; Walter P Abhayaratna; Dennis H Lau; Prashanthan Sanders
Journal:  J Am Coll Cardiol       Date:  2015-06-22       Impact factor: 24.094

6.  Long-Term Effect of Goal-Directed Weight Management in an Atrial Fibrillation Cohort: A Long-Term Follow-Up Study (LEGACY).

Authors:  Rajeev K Pathak; Melissa E Middeldorp; Megan Meredith; Abhinav B Mehta; Rajiv Mahajan; Christopher X Wong; Darragh Twomey; Adrian D Elliott; Jonathan M Kalman; Walter P Abhayaratna; Dennis H Lau; Prashanthan Sanders
Journal:  J Am Coll Cardiol       Date:  2015-03-16       Impact factor: 24.094

7.  Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study.

Authors:  Thomas J Wang; Martin G Larson; Daniel Levy; Ramachandran S Vasan; Eric P Leip; Philip A Wolf; Ralph B D'Agostino; Joanne M Murabito; William B Kannel; Emelia J Benjamin
Journal:  Circulation       Date:  2003-05-27       Impact factor: 29.690

8.  The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study.

Authors:  A D Krahn; J Manfreda; R B Tate; F A Mathewson; T E Cuddy
Journal:  Am J Med       Date:  1995-05       Impact factor: 4.965

9.  No Decline in the Risk of Stroke Following Incident Atrial Fibrillation Since 2000 in the Community: A Concerning Trend.

Authors:  Alanna M Chamberlain; Robert D Brown; Alvaro Alonso; Bernard J Gersh; Jill M Killian; Susan A Weston; Véronique L Roger
Journal:  J Am Heart Assoc       Date:  2016-06-13       Impact factor: 5.501

10.  Atrial Fibrillation Begets Heart Failure and Vice Versa: Temporal Associations and Differences in Preserved Versus Reduced Ejection Fraction.

Authors:  Rajalakshmi Santhanakrishnan; Na Wang; Martin G Larson; Jared W Magnani; David D McManus; Steven A Lubitz; Patrick T Ellinor; Susan Cheng; Ramachandran S Vasan; Douglas S Lee; Thomas J Wang; Daniel Levy; Emelia J Benjamin; Jennifer E Ho
Journal:  Circulation       Date:  2016-01-08       Impact factor: 29.690

View more
  5 in total

1.  Associations between relevant cardiovascular pharmacotherapies and incident heart failure in patients with atrial fibrillation: a cohort study in primary care.

Authors:  Per Wändell; Axel C Carlsson; Martin J Holzmann; Johan Ärnlöv; Jan Sundquist; Kristina Sundquist
Journal:  J Hypertens       Date:  2018-09       Impact factor: 4.844

2.  The association between relevant co-morbidities and prevalent as well as incident heart failure in patients with atrial fibrillation.

Authors:  Per Wändell; Axel C Carlsson; Martin J Holzmann; Johan Ärnlöv; Jan Sundquist; Kristina Sundquist
Journal:  J Cardiol       Date:  2018-02-01       Impact factor: 3.159

3.  Atrial fibrillation-induced tachycardiomyopathy and heart failure: an underappreciated and elusive condition.

Authors:  Antonis S Manolis; Theodora A Manolis; Antonis A Manolis; Helen Melita
Journal:  Heart Fail Rev       Date:  2022-03-23       Impact factor: 4.654

4.  Polypharmacy, Adverse Outcomes, and Treatment Effectiveness in Patients ≥75 With Atrial Fibrillation.

Authors:  Nemin Chen; Aniqa B Alam; Pamela L Lutsey; Richard F MacLehose; J'Neka S Claxton; Lin Y Chen; Alanna M Chamberlain; Alvaro Alonso
Journal:  J Am Heart Assoc       Date:  2020-05-23       Impact factor: 5.501

5.  Heart failure with preserved ejection fraction: An alternative paradigm to explain the clinical implications of atrial fibrillation.

Authors:  Jonathan P Ariyaratnam; Adrian D Elliott; Ricardo S Mishima; Celine Gallagher; Dennis H Lau; Prashanthan Sanders
Journal:  Heart Rhythm O2       Date:  2021-12-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.